Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab

NCT01845844 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ranibizumab 0.3mg/0.05cc

Sponsor

Southeast Retina Center, Georgia

Collaborators

[object Object]